Acute Intracranial Hemorrhage clinical trials at University of California Health
1 research study open to eligible people
Showing trials for
Trial of Andexanet Alfa in ICH Patients Receiving an Oral FXa Inhibitor
open to eligible people ages 18 years and up
Randomized, controlled clinical trial evaluating the efficacy and safety of andexanet alfa versus usual care in patients with intracranial hemorrhage anticoagulated with a direct oral or indirect subcutaneous/intravenous anticoagulant
at UC Irvine
Last updated: